Related by context. Frequent words. (Click for all words.) 68 fusion inhibitor 68 MVA BN R 68 Nanobody 67 Scancell 67 SAR# [004] 67 WILEX 67 GVAX R 67 Initiates Phase II 66 Allovectin 7 R 66 Factor VIIa 65 AEG# 65 immunotherapeutics 65 ATL# [001] 65 Tesetaxel 65 therapeutic monoclonal antibodies 64 prophylactic vaccine 64 cancer immunotherapies 64 Cancer Vaccines 64 prophylactic vaccines 64 Ixempra 64 Daclizumab 64 Inc. Nasdaq IMGN 63 forodesine 63 StemEx 63 GRNVAC1 63 ALN TTR 63 siRNA therapeutics 63 Urocidin 63 AMD# [002] 63 GLPG# 63 registrational trial 63 Panzem R 63 deforolimus 63 targeting CD# 63 Nasdaq ENZN 63 Phase Ib II 63 outlicensing 63 vascular disrupting agent 63 ZFP Therapeutic 63 Loramyc R 63 anti CD# monoclonal 62 MOZOBIL 62 Initiate Phase 62 Clevudine 62 MEK inhibitor 62 R sorafenib tablets 62 proteasome inhibitor 62 phase IIb clinical 62 eniluracil 62 oncolytic 62 Argatroban 62 Phase III Clinical Trial 62 PEG SN# 62 multi kinase inhibitor 62 AeroLEF R 62 RNAi Therapeutics 62 INTERCEPT red 62 oncolytic virus 62 HCV protease inhibitor 61 Electroporation 61 drug conjugate 61 Aurexis 61 IMC #B 61 HGS ETR2 61 Aliskiren 61 talactoferrin 61 ThermoDox R 61 NASDAQ OSIR 61 novel RNAi therapeutics 61 ASONEP 61 GV# [001] 61 elotuzumab 61 Nasdaq VRTX 61 TLR9 agonist 61 gets USFDA nod 61 OncoVEX GM CSF 61 Chemokine 61 Idera Pharmaceuticals 61 Juvaris 61 Protexia R 61 Vaccinex 61 adenovector 61 vosaroxin 61 Azedra 61 Nexavar ® 61 liposomal formulation 61 phase IIa clinical 61 Thiarabine 61 Inc Therapeutic Competitors 61 phase IIa 61 Lipoxen 61 GAP #B# 61 Phase IIb trials 61 Nasdaq ISIS 61 ALN TTR# 61 Ingenuity Pathways Analysis 61 MAXY G# 61 antisense drug 61 SNALP 60 Bicifadine 60 ImmunoCellular Therapeutics